Find Omarigliptin manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Related ProductsRelated Products

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

FDF

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 1226781-44-7, Mk-3102, Mk3102, (2r,3s,5r)-2-(2,5-difluorophenyl)-5-(2-(methylsulfonyl)pyrrolo[3,4-c]pyrazol-5(2h,4h,6h)-yl)tetrahydro-2h-pyran-3-amine, Cvp59q4je1, Unii-cvp59q4je1
Molecular Formula
C17H20F2N4O3S
Molecular Weight
398.4  g/mol
InChI Key
MKMPWKUAHLTIBJ-ISTRZQFTSA-N
FDA UNII
CVP59Q4JE1

Omarigliptin
Omarigliptin has been used in trials studying the treatment of Type 2 Diabetes Mellitus and Chronic Renal Insufficiency.
1 2D Structure

Omarigliptin

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(2R,3S,5R)-2-(2,5-difluorophenyl)-5-(2-methylsulfonyl-4,6-dihydropyrrolo[3,4-c]pyrazol-5-yl)oxan-3-amine
2.1.2 InChI
InChI=1S/C17H20F2N4O3S/c1-27(24,25)23-7-10-6-22(8-16(10)21-23)12-5-15(20)17(26-9-12)13-4-11(18)2-3-14(13)19/h2-4,7,12,15,17H,5-6,8-9,20H2,1H3/t12-,15+,17-/m1/s1
2.1.3 InChI Key
MKMPWKUAHLTIBJ-ISTRZQFTSA-N
2.1.4 Canonical SMILES
CS(=O)(=O)N1C=C2CN(CC2=N1)C3CC(C(OC3)C4=C(C=CC(=C4)F)F)N
2.1.5 Isomeric SMILES
CS(=O)(=O)N1C=C2CN(CC2=N1)[C@@H]3C[C@@H]([C@H](OC3)C4=C(C=CC(=C4)F)F)N
2.2 Other Identifiers
2.2.1 UNII
CVP59Q4JE1
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 2-(2,5-difluorophenyl)-5-(2-(methylsulfonyl)-2,6-dihydropyrrolo(3,4-c)pyrazol-5(4h)-yl)tetrahydro-2h-pyran-3-amine

2. Mk-3102

2.3.2 Depositor-Supplied Synonyms

1. 1226781-44-7

2. Mk-3102

3. Mk3102

4. (2r,3s,5r)-2-(2,5-difluorophenyl)-5-(2-(methylsulfonyl)pyrrolo[3,4-c]pyrazol-5(2h,4h,6h)-yl)tetrahydro-2h-pyran-3-amine

5. Cvp59q4je1

6. Unii-cvp59q4je1

7. (2r,3s,5r)-2-(2,5-difluorophenyl)-5-(2-(methylsulfonyl)-2,6-dihydropyrrolo[3,4-c]pyrazol-5(4h)-yl)tetrahydro-2h-pyran-3-amine

8. (2r,3s,5r)-2-(2,5-difluorophenyl)-5-[2-(methylsulfonyl)-2,6-dihydropyrrolo[3,4-c]pyrazol-5(4h)-yl]tetrahydro-2h-pyran-3-amine

9. 2h-pyran-3-amine, 2-(2,5-difluorophenyl)-5-(2,6-dihydro-2-(methylsulfonyl)pyrrolo(3,4-c)pyrazol-5(4h)-yl)tetrahydro-,(2r,3s,5r)-

10. (2r,3s,5r)-2-(2,5-difluorophenyl)-5-(2-methylsulfonyl-4,6-dihydropyrrolo[3,4-c]pyrazol-5-yl)oxan-3-amine

11. Omarigliptin [usan]

12. Omarigliptin [usan:inn]

13. Omarigliptin [mi]

14. Omarigliptin [inn]

15. Omarigliptin [jan]

16. Omarigliptin (mk-3102)

17. Omarigliptin [who-dd]

18. Schembl827590

19. Ambz0104

20. Gtpl8402

21. Omarigliptin (jan/usan/inn)

22. Chembl2105762

23. Dtxsid70153678

24. Ex-a395

25. Chebi:134735

26. Bdbm50003020

27. Mfcd22573261

28. Nsc802900

29. S8565

30. Zinc84758480

31. Akos025289528

32. Am85511

33. Ccg-268634

34. Cs-3948

35. Db11992

36. Ds-7574

37. Nsc-802900

38. Pb39113

39. Ncgc00480770-01

40. (2r,3s,5r)-2-(2,5-difluorophenyl)-5-(2-(methanesulfonyl)-2,6-dihydropyrrolo(3,4- C)pyrazol-5(4h)-yl)oxan-3-amine

41. (2r,3s,5r)-2-(2,5-difluorophenyl)-5-(2-(methylsulfonyl)-2,6-dihydropyrrolo(3,4- C)pyrazol-5(4h)-yl)tetrahydro-2h-pyran-3-amine

42. 2h-pyran-3-amine, 2-(2,5-difluorophenyl)-5-(2,6-dihydro-2-(methylsulfonyl)pyrrolo(3,4- C)pyrazol-5(4h)-yl)tetrahydro-, (2r,3s,5r)-

43. Ac-28992

44. Hy-15981

45. D10317

46. L10002

47. J-690074

48. Q21098979

49. (2r,3s,5r)-2-(2,5-difluorophenyl)-5[2-(methylsulfonyl)-2,6-dihydropyrrolo[3,4-c]pyrazol-5(4h)-yl]tetrahydro-2h-pyran-3-amine

50. 2h-pyran-3-amine, 2-(2,5-difluorophenyl)-5-[2,6-dihydro-2-(methylsulfonyl)pyrrolo[3,4-c]pyrazol-5(4h)-yl]tetrahydro-, (2r,3s,5r)-

2.4 Create Date
2010-07-06
3 Chemical and Physical Properties
Molecular Weight 398.4 g/mol
Molecular Formula C17H20F2N4O3S
XLogP30.3
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count8
Rotatable Bond Count3
Exact Mass398.12241801 g/mol
Monoisotopic Mass398.12241801 g/mol
Topological Polar Surface Area98.8 Ų
Heavy Atom Count27
Formal Charge0
Complexity649
Isotope Atom Count0
Defined Atom Stereocenter Count3
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

API SUPPLIERS

read-more
read-more
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

Market Place

Do you need sourcing support? Ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty